BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dickman R, Maradey-Romero C, Fass R. The role of pain modulators in esophageal disorders - no pain no gain. Neurogastroenterol Motil 2014;26:603-10. [PMID: 24750261 DOI: 10.1111/nmo.12339] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Maev IV, Barkalova EV, Ovsepian MA, Andreev DN. Phenotypes of gastroesophageal reflux disease: classification, pathogenesis and diagnostic criteria: A review. Consilium Medicum 2022;24:277-285. [DOI: 10.26442/20751753.2022.5.201703] [Reference Citation Analysis]
2 Hungin APS, Scarpignato C, Keefer L, Corsetti M, Anastasiou F, Muris JWM, Mendive JM, Kahrilas PJ. Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective. Aliment Pharmacol Ther 2022;55:1492-500. [PMID: 35460095 DOI: 10.1111/apt.16930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review. Clin Gastroenterol Hepatol 2022;20:984-994.e1. [PMID: 35123084 DOI: 10.1016/j.cgh.2022.01.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
4 Xu C, Niu X, Toyokawa T. Progress on the Mechanism of Visceral Hypersensitivity in Nonerosive Reflux Disease. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/4785077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV, Mekhtiev SN, Mekhtieva OA, Metsaeva ZV, Petelin DS, Simanenkov VI, Sitkin SI, Cheremushkin SV, Chernogorova MV, Khavkin АI. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-5-117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vasiliev R, Igor Maev IM, Bakulin I, Dmitriy Bordin DB, Bakulina N, Oganezova I, Skazyvaeva E, Skalinskaya M, Yulia Embutnieks YE, Plavnik R, Lyudmila Fedulenkova LF, Tikhonov S, Mariia Zhuravleva MZ. Epidemiological and clinical risk factors for non-erosive reflux disease, erosive esophagitis and Barrett’s esophagus in Russia. GHOA 2021;12:176-180. [DOI: 10.15406/ghoa.2021.12.00482] [Reference Citation Analysis]
7 Soifer L, Tawil J, Remes-Troche JM, Valdovinos MA, Schmulson M; GERD Collaboration Group of the Sociedad Latinoamericana de Neurogastroenterología. Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterología (SLNG). Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00118-3. [PMID: 34794927 DOI: 10.1016/j.rgmxen.2021.11.004] [Reference Citation Analysis]
8 Kahrilas PJ, Savarino E, Anastasiou F, Bredenoord AJ, Corsetti M, Lagergren J, Mendive J, Nelson S, Roman S, Zerbib F, Hungin P. The tapestry of reflux syndromes: translating new insight into clinical practice. Br J Gen Pract 2021;71:470-3. [PMID: 34593403 DOI: 10.3399/bjgp21X717329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Soifer L, Tawil J, Remes-Troche JM, M A Valdovinos, Schmulson M; grupo de colaboración de ERGE de la Sociedad Latinoamericana de Neurogastroenterología. Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterología (SLNG). Rev Gastroenterol Mex 2021:S0375-0906(21)00060-4. [PMID: 34294483 DOI: 10.1016/j.rgmx.2021.02.006] [Reference Citation Analysis]
10 Shibli F, Fass R. Refractory Heartburn. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch26] [Reference Citation Analysis]
11 Patel D, Fass R, Vaezi M. Untangling Nonerosive Reflux Disease From Functional Heartburn. Clin Gastroenterol Hepatol 2021;19:1314-26. [PMID: 32246998 DOI: 10.1016/j.cgh.2020.03.057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 de Bortoli N, Gyawali PC, Roman S, Tolone S, Sifrim D, Tutuian R, Penagini R, Pandolfino JE, Savarino EV. Hypercontractile Esophagus From Pathophysiology to Management: Proceedings of the Pisa Symposium. Am J Gastroenterol 2021;116:263-73. [PMID: 33273259 DOI: 10.14309/ajg.0000000000001061] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
13 Yadlapati R, Masihi M, Gyawali CP, Carlson DA, Kahrilas PJ, Nix BD, Jain A, Triggs JR, Vaezi MF, Kia L, Kaizer A, Pandolfino JE. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial. Gastroenterology 2021;160:174-182.e1. [PMID: 32949568 DOI: 10.1053/j.gastro.2020.09.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
14 Blaga TS, Dumitrascu DL, Pop AV, Grad S. The interactions between gut and brain in gastrointestinal disorders. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes 2021. [DOI: 10.1016/b978-0-12-821927-0.00008-5] [Reference Citation Analysis]
15 Fass R, Zerbib F, Gyawali CP. AGA Clinical Practice Update on Functional Heartburn: Expert Review. Gastroenterology 2020;158:2286-93. [PMID: 32017911 DOI: 10.1053/j.gastro.2020.01.034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
16 Liu J, Kou F, Tan X, Dai Y, Xie C, Li X, Shi L, Mao T, Shi X, Li J. Hewei Jiangni granule alleviates visceral hypersensitivity in a rat model of non-erosive reflux disease via transient receptor potential channel signaling. Journal of Traditional Chinese Medical Sciences 2020;7:162-70. [DOI: 10.1016/j.jtcms.2020.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Cai JX, Chan WW. Spastic Motor Disorders. Evaluation and Management of Dysphagia 2020. [DOI: 10.1007/978-3-030-26554-0_8] [Reference Citation Analysis]
18 Fass OZ, Fass R. Functional Dysphagia. Evaluation and Management of Dysphagia 2020. [DOI: 10.1007/978-3-030-26554-0_10] [Reference Citation Analysis]
19 Fass R. Esophageal Disorders, Functional. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.11094-3] [Reference Citation Analysis]
20 Fass R, Shibli F, Tawil J. Diagnosis and Management of Functional Chest Pain in the Rome IV Era. J Neurogastroenterol Motil 2019;25:487-98. [PMID: 31587539 DOI: 10.5056/jnm19146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ribolsi M, Giordano A, Guarino MPL, Tullio A, Cicala M. New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Review of Gastroenterology & Hepatology 2019;13:761-9. [DOI: 10.1080/17474124.2019.1645596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Sobrino-cossío S, Teramoto-matsubara O, Mateos-pérez G, Abdo-francis J, Tawil J, Olguín-ramírez C, Orozco-gamiz A, Galvis-garcía E. La búsqueda del Grial: una carrera por la supresión ácida. Revista de Gastroenterología de México 2019;84:344-356. [DOI: 10.1016/j.rgmx.2019.04.002] [Reference Citation Analysis]
23 Sobrino-cossío S, Teramoto-matsubara O, Mateos-pérez G, Abdo-francis J, Tawil J, Olguín-ramírez C, Orozco-gamiz A, Galvis-garcía E. In search of the grail: A race for acid suppression. Revista de Gastroenterología de México (English Edition) 2019;84:344-56. [DOI: 10.1016/j.rgmxen.2019.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Guadagnoli LA, Pandolfino JE, Yadlapati R. Functional Swallowing Disorders. Gastrointestinal and Liver Disorders in Women’s Health 2019. [DOI: 10.1007/978-3-030-25626-5_2] [Reference Citation Analysis]
25 Konečný Š, Kroupa R, Dolina J. Actualities in functional esophageal disorders. Med Pro Praxi 2018;15:263-266. [DOI: 10.36290/med.2018.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
26 Chi ZC. Reflux hypersensitivity. Shijie Huaren Xiaohua Zazhi 2018; 26(15): 885-891 [DOI: 10.11569/wcjd.v26.i15.885] [Reference Citation Analysis]
27 Akiyama J, Kuribayashi S, Baeg MK, Bortoli N, Valitova E, Savarino EV, Kusano M, Triadafilopoulos G. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci 2018;1434:70-83. [DOI: 10.1111/nyas.13850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhong C, Liu K, Wang K, Liu H, Su H, Wu J, Duan L. Developing a diagnostic understanding of GERD phenotypes through the analysis of levels of mucosal injury, immune activation, and psychological comorbidity. Dis Esophagus 2018;31. [PMID: 29757356 DOI: 10.1093/dote/doy039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
29 Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology 2018;154:302-18. [PMID: 28827081 DOI: 10.1053/j.gastro.2017.07.049] [Cited by in Crossref: 157] [Cited by in F6Publishing: 159] [Article Influence: 31.4] [Reference Citation Analysis]
30 Blonski W, Richter JE. Chest Pain of Esophageal Origin and Reflux Hypersensitivity. Gastrointestinal Motility Disorders 2018. [DOI: 10.1007/978-3-319-59352-4_3] [Reference Citation Analysis]
31 Yamasaki T, Fass R. Reflux Hypersensitivity: A New Functional Esophageal Disorder. J Neurogastroenterol Motil 2017;23:495-503. [PMID: 28992673 DOI: 10.5056/jnm17097] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
32 Ang D, How CH, Ang TL. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy. Singapore Med J 2016;57:546-51. [PMID: 27779277 DOI: 10.11622/smedj.2016167] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
33 Park M. Understanding the Rome IV: Esophageal Disorders. Korean J Med 2017;92:354-361. [DOI: 10.3904/kjm.2017.92.4.354] [Reference Citation Analysis]
34 Sobrino-cossío S, Soto-pérez J, Coss-adame E, Mateos-pérez G, Teramoto Matsubara O, Tawil J, Vallejo-soto M, Sáez-ríos A, Vargas-romero J, Zárate-guzmán A, Galvis-garcía E, Morales-arámbula M, Quiroz-castro O, Carrasco-rojas A, Remes-troche J. Post-fundoplication symptoms and complications: Diagnostic approach and treatment. Revista de Gastroenterología de México (English Edition) 2017;82:234-247. [DOI: 10.1016/j.rgmxen.2017.02.001] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
35 Yamasaki T, Fass R. Noncardiac chest pain: diagnosis and management. Curr Opin Gastroenterol 2017;33:293-300. [PMID: 28463855 DOI: 10.1097/MOG.0000000000000374] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
36 Sebastián Domingo JJ. The new Rome criteria (IV) of functional digestive disorders in clinical practice. Medicina Clínica (English Edition) 2017;148:464-468. [DOI: 10.1016/j.medcle.2016.12.070] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, O'Connor G, Grati M, Mittal J, Yan D, Eshraghi AA, Deo SK, Daunert S, Liu XZ. Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. J Cell Physiol 2017;232:2359-72. [PMID: 27512962 DOI: 10.1002/jcp.25518] [Cited by in Crossref: 231] [Cited by in F6Publishing: 244] [Article Influence: 38.5] [Reference Citation Analysis]
38 Sebastián Domingo JJ. The new Rome criteria (IV) of functional digestive disorders in clinical practice. Med Clin (Barc) 2017;148:464-8. [PMID: 28153434 DOI: 10.1016/j.medcli.2016.12.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
39 Sobrino-Cossío S, Soto-Pérez JC, Coss-Adame E, Mateos-Pérez G, Teramoto Matsubara O, Tawil J, Vallejo-Soto M, Sáez-Ríos A, Vargas-Romero JA, Zárate-Guzmán AM, Galvis-García ES, Morales-Arámbula M, Quiroz-Castro O, Carrasco-Rojas A, Remes-Troche JM. Post-fundoplication symptoms and complications: Diagnostic approach and treatment. Rev Gastroenterol Mex 2017;82:234-47. [PMID: 28065591 DOI: 10.1016/j.rgmx.2016.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
40 Lee K, Kwon HJ, Kim IY, Yoo KH, Lee S, Min YW, Rhee PL. Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain. Gut Liver 2016;10:152-5. [PMID: 26087786 DOI: 10.5009/gnl14294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology 2016:S0016-5085(16)00178-5. [PMID: 27144625 DOI: 10.1053/j.gastro.2016.02.012] [Cited by in Crossref: 316] [Cited by in F6Publishing: 320] [Article Influence: 45.1] [Reference Citation Analysis]
42 Maradey-romero C, Fass R. Novel Upcoming Therapies. Diagnosis and Treatment of Gastroesophageal Reflux Disease 2016. [DOI: 10.1007/978-3-319-19524-7_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Hussain ZH, Henderson EE, Maradey-Romerao C, George N, Fass R, Lacy BE. The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum. Clin Transl Gastroenterol. 2015;6:e106. [PMID: 26270485 DOI: 10.1038/ctg.2015.32] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
44 Maradey-Romero C, Fass R. Antidepressants for functional esophageal disorders: evidence- or eminence-based medicine? Clin Gastroenterol Hepatol 2015;13:260-2. [PMID: 25283580 DOI: 10.1016/j.cgh.2014.09.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
45 Atluri DK, Chandar AK, Fass R, Falck-Ytter Y. Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain. Aliment Pharmacol Ther 2015;41:167-76. [PMID: 25412947 DOI: 10.1111/apt.13015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]